Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: Early prediction of tumour regression rate

British Journal of Radiology

Volumn 72, Issue DEC., 1999, Pages 1177-1184

  Gong, Q Y ^a,b   Brunt, J N H ^a   Romaniuk, C S ^a   Oakley, J P ^c   Tan, L T ^a   Roberts, N ^b   Whitehouse, G H ^b   Jones, B ^a  

^a CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; FEMALE; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SIGNAL NOISE RATIO; TREATMENT PLANNING; TUMOR REGRESSION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 0033398114     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.72.864.10703475     Document Type: Article

References (47)

1. Hoskins WJ, Perez CA, Young RC. Gynecologic tumors. In: DeVita VT JR, Hellmann S, Rosenberg SA, editors. Cancer principles and practice of oncology, 4th edn. Philadelphia: Lippincott, 1993:1152-225.
2. Grossman I, Kurohara SS, Webster JH, George FW. The prognostic significance of tumor response during radiotherapy in cervical carcinoma. Radiology 1973;107:411-5.
3. Hardt N, van Nagell JR, Hanson M, Donaldson E, Yoneda J, Maruyama Y. Radiation-induced tumor regression as a prognostic factor in patients with invasive cervical cancer. Cancer 1982;49:35-9.
4. Hong JH, Chen MS, Lin FJ, Tang SG. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 1992;22:913-7.
5. Marcial V, Bosch A. Radiation-induced tumor regression in carcinoma of the uterine cervix: prognostic significance. AJR 1970;108:113-23.
6. Burghardt E, Hofmann HMH, Ebner F, Haas J, Tamussino K, Justich E. Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol 1989;33:61-7.
7. Hricak H, Quivey JM, Campos Z, et al. Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993;27:791-801.
8. Greco A, Mason P, Leung AWL, Dische S, McIndoe GAJ, Anderson MC. Staging of carcinoma of the uterine cervix: MRI surgical correlation. Clin Radiol 1989;40:401-5.
9. Mayr NA, Tali ET, Yuh WTC, et al. Cervical cancer: application of MRI in radiation therapy. Radiology 1993;189:601-8.
10. Tan LT, Romaniuk CS, Brunt J, Kingston RE, Jones B. The use of serial MRI to measure changes in tumour volume during radiotherapy for carcinoma of the cervix. In: Faulkner K, Carey B, Crellin A, Harrison RM, editors. Quantitative imaging in oncology. Proceedings of the 19th LH Gray Conference. London: British Institute of Radiology, 1996:150-2.
11. Hawnaur JM, Johnson RJ, Carrington BM, Hunter RD. Predictive value of clinical examination, transrectal ultrasound and magnetic resonance imaging prior to radiotherapy in carcinoma of the cervix. Br J Radiol 1998;71:819-27.
12. Seki H, Azumi R, Kimura M, Sakai K. Stromal invasion by carcinoma of the cervix: assessment with dynamic MR imaging. AJR 1997;168:1579-85.
13. Maeda M, Itoh S, Kimura H, et al. Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. AJR 1994;163:181-6.
14. Brix G, Rempp K, Guckel F, Hoffmann U, Semmler W, Lorenz WJ. Quantitative assessment of tissue microcirculation by dynamic contrast-enhanced MR imaging. Adv MRI Contrast 1994;2: 68-77.
15. Guckel F, Brix G, Rempp K, Rother J, Georgi M. Assessment of cerebral haemodynamics in patients with vascular disorders and brain tumors. Adv MRI Contrast 1994;2:94-100.
16. Kucharczyk J, Vexler ZS, Roberts TP, et al. Echoplanar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 1993;188:711 -7.
17. Hoffmann U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR-mammography. Magn Reson Med 1995;33:506-14.
18. Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MRI. JCAT 1991;15:621-8.
19. Tan LT, Jones B, Green JA, Kingston RE, Clark Pl. Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy. Br J Radiol 1996;69:165-71.
20. International Federation of Gynecology and Obstetrics (FIGO). Changes in the definition of clinical staging for the cervix and ovary. Am J Obstet Gynecol 1987;56:263-4.
21. Bentzen JKD. Why don't we use a "Cavalieri"? Eur J Cancer 1994;30a:421-2.
22. Roberts N, Cruz-Orive LM, Reid NMK, Brodie DA, Bourne M, Edwards RHT. Unbiased estimation of human body composition by the Cavalieri method using magnetic resonance imaging. J Micros 1993;171:239-53.
23. Roberts N, Garden AS, Cruz-Orive LM, Whitehouse GH, Edwards RHT. Estimation of fetal volume by magnetic resonance imaging and stereology. Br J Radiol 1994;67:1067-77.
24. Gong QY, Roberts N, Garden AS, Whitehouse GH. Fetal and fetal brain volume estimation in the third trimester of human pregnancy using gradient echo MR imaging. Magn Reson Imaging 1998;16:235-40.
25. Henkelman RM. Measurement of signal intensities in the presence of noise in MR images. Med Phys 1985;12:232-3.
26. Carroll RJ, Ruppert D. Transformation and weighting in regression monographs on statistics and applied probability. New York: Chapman and Hall, 1988.
27. Dische S, Bennett MH, Saunders MI, Anderson P. Tumour regression as a guide to prognosis: a clinical study. Br J Radiol 1980;53:454-61.
28. Gong QY, Tan LT, Romaniuk CS, Jones B, Brunt JNH. Roberts N. Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability. Br J Radiol 1999;72:62-72.
29. Jones B, Bleasdale C. Effect of overall time when radiotherapy includes teletherapy and brachytherapy: a mathematical model. Br J Radiol 1994;67:63-70.
30. Jones B, Dale RG, Bleasdale C, Tan LT, Davies M. A mathematical model of intraluminal and intracavitary brachytherapy. Br J Radiol 1994;67:805-12.
31. Jones B, Dale RG. Estimation of tumour hypoxic fraction from clinical data sets compatible with accelerated repopulation. Acta Oncol 1998;37:263-8.
32. Dale RG, Jones B. The clinical radiobiology of brachytherapy. Br J Radiol 1998;71:465-83.
33. Hawighorst H, Knapstein PG, Weikel W, et al. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 1996; 201:531-9.
34. Hawighorst H, Knapstein PG, Schaefler U, et al. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumor from benign conditions. AJR 1996;166:401-8.
35. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992;184:243-8.
36. Verstraete KL, De-Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging: parametric first-pass images depict tissue vascularization and perfusion. Radiology 1994;192:835-43.
37. deVries A. Judmaier W, Griebel J, et al. Monitoring of tumor microcirculation during fractionated radiotherapy in patients with rectal carcinomas: a clinical study using contrast enhanced MR imaging (abstract). Int J Radiat Oncol Biol Phys 1996; 36:377.
38. Griebel J, Gneiting T, de Vries A, Debbage P, Lukas P, Kellerer AM. In vivo monitoring of microcirculatory tumor parameters during fractionated radiotherapy: a study in mouse mammary adenocarcinoma using contrast enhanced magnetic resonance imaging (abstract). Int J Radiat Oncol Biol Phys 1996;36(Suppl):175.
39. Semmler W, Kopke J, Niendorf HP, et al. Gd-DTPA-enhanced MRI and radiation therapy of brain tumors. In: Bydder G, Felix R, Bucheler E, editors. Contrast media in MRI, 1st edn. Berlin: Medicom, 1990:119-25.
40. Kallinowski F, Schlenger KH, Kloes M, Stohrer M, Vaupel P. Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo. Int J Cancer 1989;44: 266-72.
41. Kallinowski F, Schlenger KH, Runkel S, et al. Blood flow, metabolism, cellular micro-environment, and growth rate of human tumor xenografts. Cancer Res 1989;49:3759-64.
42. Chaplin DJ, Olive PL, Durand RE. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 1987;47:597-601.
43. Mayr NA, Yuh WTC, Magnotta VA, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996;36:623-33.
44. Yuh WTC, Mayr NA, Zheng J, et al. Can combined volume and perfusion analysis improve the prediction of tumor control in cervical cancer? (abstract). Int J Radiat Oncol Biol Phys 1996; 36(Suppl):323.
45. Hansgen G, Hansgen K, Dunst J. Oxygen status of cervical cancers prior and during definitive radiotherapy: possible impact of pretreatment with INF-α-2a-Retinol acid on oxygenation (abstract). Int J Radiat Oncol Biol Phys 1996;36(Suppl):324.
46. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
47. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathological findings and tumour angiogenesis. Radiology 1996;200:639-49.